 | • レポートコード：TPM-DJ140 • 出版社/出版日：Transparency Market Research / 2019年4月12日 • レポート形態：英文、PDF、156ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、カスポファンギンの世界市場について調べ、カスポファンギンの市場規模、市場動向、市場シェア、市場環境、市場予測、関連企業情報などをまとめました。 |
Caspofungin Market: Overview
This report on the global caspofungin market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary, including a snapshot that provides overall information of various market segments. The research is a combination of primary and secondary researches. Primary research formed the bulk of the research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2017 to 2027, considering the macro and micro environmental factors. Growth rate for each segment of the global caspofungin market has been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining the market and opportunities has been provided in the overview section. The report also provides insights into the key trends of the caspofungin market. The report includes market attractiveness analysis of the major segments that provides a thorough analysis of the overall competitive scenario in the global caspofungin market.
Market revenue in terms of US$ Mn for the period between 2017 and 2027 along with the compound annual growth rate (CAGR %) from 2019 to 2027 are provided for all the segments, considering 2018 as the base year. The year-on-year growth of the global caspofungin market for each segment is also reflected. Additionally, market-related factors such as favorable reimbursement scenario, expanding distribution channels of caspofungin, and historical year-on-year growth have been taken into consideration while estimating the market size.
Global Caspofungin Market: Key Segments
Based on indication, the global caspofungin market has been segmented into candidiasis and thrush. In terms of distribution channel, the global market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.
Global Caspofungin Market: Regional Outlook
In terms of region, the global caspofungin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Additionally, the regions have been divided into major countries/sub-regions. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Australia & New Zealand, Japan, India, Brazil, GCC Countries, South Africa, Israel, and Mexico.
Companies Mentioned in Report
The report also profiles major players in the global caspofungin market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Mylan N.V , Merck & Co., Inc., Fresenius SE & Co. KGaA, Gland Pharma Limited, Xellia Pharmaceuticals, and Novartis AG.
The global caspofungin market has been segmented as follows:
Global Caspofungin Market, by Indication
Candidiasis
Thrush
Global Caspofungin Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Caspofungin Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
Australia & New Zealand
Japan
China
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 3 Executive Summary
3.1 Global Caspofungin Market Snapshot
3.2 Key Industry Developments
Section 4 Market Overview
4.1 Caspofungin Market Taxonomy
4.2 Caspofungin Drug Introduction
4.3 Global Caspofungin Market Size (US$ Mn) Forecast, 2017–2027
4.4 Global Caspofungin Market: Market Outlook
4.5 Rise in incidence of invasive candidiasis across the globe
4.5.1.Rise in geriatric population
4.5.2.Advantages of echinocandins over other antifungal
4.5.3.Restraints
4.5.3.1 Availability of Generic Drugs
4.5.3.2 Emergence of resistant species
4.5.4 Opportunities
4.5.4.1 Echinocandins, as first line of therapy in candidiasis
4.5.4.2 Expansion of Research and Development in Emerging Markets
Section 5 Key Insights
5.1 Clinical Trial Pipeline Analysis
5.2 Disease Prevalence & Incidence Rate globally with key countries
5.3 Supply Chain Analysis
5.4 Pricing Analysis by Manufacturers
Section 6 Global Caspofungin Market Analysis, by Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Value Share Analysis, by Indication
6.4 Market Value Forecast, by Indication, 2017–2027
6.5 Market Analysis, by Indication, 2017–2027
6.5.1 Candidiasis
6.5.2 Thrush
6.6 Market Attractiveness, by Indication
Section 7 Global Caspofungin Market Analysis, by Distribution Channel
7.1 Key Findings
7.2 Introduction
7.3 Market Value Share Analysis, by Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2 Retail Pharmacies
7.5.3 Online Pharmacies
7.6 Market Attractiveness, by Distribution Channel
Section 8 Global Caspofungin Market Analysis, by Region
8.1 Market Value Share Analysis, by Region
8.2 Market Forecast, by Region
8.3 Global Caspofungin Market Attractiveness Analysis, by Region
Section 9 North America Caspofungin Market Analysis
9.1 Market Overview
9.2 Market Value Share Analysis, by Indication
9.3 Caspofungin Market Forecast, by Indication
9.4 Market Value Share Analysis, by Distribution Channel
9.5 Caspofungin Market Forecast, by Distribution Channel
9.6 U.S.
9.6.1 Canada
9.7 Market Attractiveness Analysis
9.7.1 By Country
9.7.2 By Indication
9.7.3 By Distribution Channel
Section 10 Europe Caspofungin Market Analysis
10.1 Market Overview
10.2 Market Value Share Analysis, by Indication
10.3 Caspofungin Market Forecast, by Indication
10.4 Market Value Share Analysis, by Distribution Channel
10.5 Caspofungin Market Forecast, by Distribution Channel
10.6 Market Value Share Analysis, by Country/Sub-region
10.7 Market Forecast, by Country/Sub-region
10.7.1 Germany
10.7.2 U.K.
10.7.3 France
10.7.4 Spain
10.7.5 Italy
10.7.6 Rest of Europe
10.8 Market Attractiveness Analysis
10.8.1 By Country/Sub-region
10.8.2 By Indication
10.8.3 By Distribution Channel
Section 11 Asia Pacific Caspofungin Market Analysis
11.1 Market Overview
11.2 Market Value Share Analysis, by Indication
11.3 Caspofungin Market Forecast, by Indication
11.4 Market Value Share Analysis, by Distribution Channel
11.5 Caspofungin Market Forecast, by Distribution Channel
11.6 Market Value Share Analysis, by Country/Sub-region
11.7 Market Forecast, by Country/Sub-region
11.7.1 China
11.7.2 Japan
11.7.3 India
11.7.4 Australia & New Zealand
11.7.5 Rest of Asia Pacific
11.8 Market Attractiveness Analysis
11.8.1 By Country/Sub-region
11.8.2 By Indication
11.8.3 By Distribution Channel
Section 12 Latin America Caspofungin Market Analysis
12.1 Market Overview
12.2 Market Value Share Analysis, by Indication
12.3 Caspofungin Market Forecast, by Indication
12.4 Market Value Share Analysis, by Distribution Channel
12.5 Caspofungin Market Forecast, by Distribution Channel
12.6 Market Value Share Analysis, by Country/Sub-region
12.7 Market Forecast, by Country/Sub-region
12.7.1 Brazil
12.7.2 Mexico
12.7.3 Rest of Latin America
12.8 Market Attractiveness Analysis
12.8.1 By Country/Sub-region
12.8.2 By Indication
12.8.3 By Distribution Channel
Section 13 Middle East & Africa (MEA) Caspofungin Market Analysis
13.1 Market Overview
13.2 Market Value Share Analysis, by Indication
13.3 Caspofungin Market Forecast, by Indication
13.4 Market Value Share Analysis, by Distribution Channel
13.5 Caspofungin Market Forecast, by Distribution Channel
13.6 Market Value Share Analysis, by Country/Sub-region
13.7 Market Forecast, by Country/Sub-region
13.7.1 GCC Countries
13.7.2 South Africa
13.7.3 Israel
13.7.4 Rest of MEA
13.8 Market Attractiveness Analysis
13.8.1 By Country/Sub-region
13.8.2 By Indication
13.8.3 By Distribution Channel
Section 14 Company Profiles
14.1 Market Player – Competition Matrix (By Tier and Size of companies)
14.2 Market Share Analysis, by Company, 2017
14.3 Company Profile
14.3.1 Teva Pharmaceutical Industries Ltd.
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Financial Overview
14.3.1.3 Product Portfolio
14.3.1.4 SWOT Analysis
14.3.1.5 Strategic Overview
14.3.2 Novartis AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Financial Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Strategic Overview
14.3.3 Mylan N.V.
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Financial Overview
14.3.3.3 Product Portfolio
14.3.3.4 SWOT Analysis
14.3.3.5 Strategic Overview
14.3.4 Merck & Co., Inc.
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Financial Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Strategic Overview
14.3.5 Fresenius SE & Co. KGaA
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Financial Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Strategic Overview
14.3.6 Gland Pharma Limited (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Financial Overview
14.3.6.3 Product Portfolio
14.3.6.4 SWOT Analysis
14.3.6.5 Strategic Overview
14.3.7 Xellia Pharmaceuticals
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Financial Overview
14.3.7.3 Product Portfolio
14.3.7.4 SWOT Analysis
14.3.7.5 Strategic Overview
Table 02: Caspofungin Brands in Germany and their Prices
Table 03: Pipeline Analysis, by Phase 3 Drugs
Table 04: Country Estimated Burden and Prevalence Rate of Candidiasis
Table 05: List of Prescription Products
Table 06: List of Prescription Products
Table 07: List of Generic Prescription Products
Table 08: Global Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 09: Global Caspofungin Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: Global Caspofungin Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11: North America Caspofungin Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 12: North America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 13: North America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 14: Europe Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 16: Europe Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 19: Asia Pacific Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 22: Latin America Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 23: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 25: Middle East & Africa Caspofungin Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027